Project Description
Luoda has developed a mastitis challenge model of Streptococcus uberis, one of the most common causes of mastitis worldwide, with the goal of assessing the safety, efficacy and milk withholding period of a novel intramammary product. Luoda has already tested one of its lead compounds against Streptococcus uberis in cattle and has demonstrated effectiveness equivalent to a leading commercial product currently available. A challenge model of Staphylococcus aureus mastitis has also been developed.
![](http://luodapharma.com/wp-content/uploads/2017/05/cow-adjusted.jpg)
Target
Bovine mastitis is most commonly caused by bacterial infection of the cow’s udder which reduces milk production and is potentially fatal.
Project Details
Development Status: | Clinical Development Ongoing |
Licence Status: | First stage funding obtained |
Commercialisation Date: | Estimated 2020 |